Northern Trust Corp Takeda Pharmaceutical CO LTD Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Northern Trust Corp holds 2,029,885 shares of TAK stock, worth $30.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,029,885

Previous 1,639,913 23.78%

Holding current value

$30.7 Million

Previous $24.4 Million 28.69%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$13.71 - $15.46 $5.35 Million - $6.03 Million	389,972 Added 23.78%	2,029,885 $31.4 Million
Q1 2025 May 13, 2025	SELL	$12.89 - $15.19 $3.01 Million - $3.55 Million	-233,675 Reduced 12.47%	1,639,913 $24.4 Million
Q4 2024 Feb 14, 2025	BUY	$13.01 - $14.43 $3.1 Million - $3.44 Million	238,161 Added 14.56%	1,873,588 $24.8 Million
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $583,726 - $677,122	44,902 Added 2.82%	1,635,427 $23.2 Million
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $3.47 Million - $3.77 Million	-275,628 Reduced 14.77%	1,590,525 $20.6 Million
Q1 2024 May 14, 2024	BUY	$13.89 - $15.04 $722,196 - $781,989	51,994 Added 2.87%	1,866,153 $25.9 Million
Q4 2023 Feb 13, 2024	SELL	$13.36 - $15.43 $5.02 Million - $5.8 Million	-376,111 Reduced 17.17%	1,814,159 $25.9 Million
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $1.28 Million - $1.39 Million	-84,881 Reduced 3.73%	2,190,270 $33.9 Million
Q2 2023 Aug 11, 2023	SELL	$15.57 - $17.11 $7,567 - $8,315	-486 Reduced 0.02%	2,275,151 $35.7 Million
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $1.61 Million - $1.73 Million	-105,217 Reduced 4.42%	2,275,637 $37.5 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $2.34 Million - $2.94 Million	188,267 Added 8.59%	2,380,854 $37.2 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $864,409 - $1.93 Million	-67,532 Reduced 2.99%	2,192,587 $28.4 Million
Q2 2022 Aug 12, 2022	BUY	$13.12 - $15.03 $534,784 - $612,637	40,761 Added 1.84%	2,260,119 $31.7 Million
Q1 2022 May 13, 2022	SELL	$13.54 - $15.35 $1.64 Million - $1.86 Million	-120,979 Reduced 5.17%	2,219,358 $31.8 Million
Q4 2021 Feb 08, 2022	BUY	$13.17 - $16.4 $1.02 Million - $1.27 Million	77,503 Added 3.43%	2,340,337 $31.9 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $32.1 Million - $34 Million	-1,970,848 Reduced 46.55%	2,262,834 $37.1 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $5.38 Million - $6.06 Million	-325,344 Reduced 7.14%	4,233,682 $71.3 Million
Q1 2021 May 12, 2021	BUY	$16.71 - $19.9 $3.01 Million - $3.58 Million	179,997 Added 4.11%	4,559,026 $83.2 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $2.04 Million - $2.52 Million	132,842 Added 3.13%	4,379,029 $79.7 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $7.34 Million - $8.24 Million	429,250 Added 11.25%	4,246,187 $75.8 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $5.89 Million - $7.87 Million	403,825 Added 11.83%	3,816,937 $68.4 Million
Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $4.33 Million - $6.75 Million	-332,342 Reduced 8.87%	3,413,112 $51.8 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $2.87 Million - $3.55 Million	-170,219 Reduced 4.35%	3,745,454 $73.9 Million
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $2.38 Million - $2.66 Million	-147,635 Reduced 3.63%	3,915,673 $67.4 Million
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $2.58 Million - $3.19 Million	-155,542 Reduced 3.69%	4,063,308 $71.9 Million
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $13.4 Million - $17.3 Million	803,851 Added 23.54%	4,218,850 $85.9 Million
Q4 2018 Feb 12, 2019	BUY	$15.64 - $21.1 $53.4 Million - $72.1 Million	3,414,999 New	3,414,999 $57.4 Million

Others Institutions Holding TAK

# of Institutions

370

Shares Held

73.1M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $46.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Takeda Pharmaceutical CO LTD Transaction History